As on Wednesday, Kintara Therapeutics Inc (NASDAQ: KTRA) started slowly as it slid -2.58% to $0.13, before settling in for the price of $0.13 at the close. Taking a more long-term approach, KTRA posted a 52-week range of $0.08-$5.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 49.09%. This publicly-traded company’s shares outstanding now amounts to $55.30 million, simultaneously with a float of $55.20 million. The organization now has a market capitalization sitting at $7.09 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1077, while the 200-day Moving Average is $1.9201.
Kintara Therapeutics Inc (KTRA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Kintara Therapeutics Inc’s current insider ownership accounts for 0.19%, in contrast to 0.44% institutional ownership.
Kintara Therapeutics Inc (KTRA) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 6/29/2023, the company posted -$1.95 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$1.05) by -$0.9. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Kintara Therapeutics Inc (NASDAQ: KTRA) Trading Performance Indicators
Let’s observe the current performance indicators for Kintara Therapeutics Inc (KTRA). It’s Quick Ratio in the last reported quarter now stands at 0.63. The Stock has managed to achieve an average true range (ATR) of 0.02.
In the same vein, KTRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.98.
Technical Analysis of Kintara Therapeutics Inc (KTRA)
Through scrutinizing the latest numbers posted by the [Kintara Therapeutics Inc, KTRA], it can be observed that its last 5-days Average volume of 9.9 million was lower the volume of 14.6 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 28.48% While, its Average True Range was 0.0218.
Raw Stochastic average of Kintara Therapeutics Inc (KTRA) in the period of the previous 100 days is set at 11.39%, which indicates a major fall in contrast to 27.47% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 227.57% that was higher than 150.14% volatility it exhibited in the past 100-days period.
